Back to search
FDAFDA · Food and drugs·Recall number D-0023-2022

AirDuo Digihaler 55/14 (fluticasone propionate 55 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva Respiratory, LLC Frazer, PA 19355, Manufactured in Ireland, NDC 59310-111-06

Published October 27, 2021 · Recall initiated: September 22, 2021

Summary

FDA records drug Class II recall D-0023-2022, published October 27, 2021 and initiated September 22, 2021. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 1,978 inhalers; Lot: AFR16A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
USA Nationwide
Lot
AFR16A
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was AirDuo Digihaler 55/14 (fluticasone propionate 55 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva Respiratory, LLC Frazer, PA 19355, Manufactured in Ireland, NDC 59310-111-06 recalled?

Yes. FDA published recall D-0023-2022 on October 27, 2021. Reported hazard: Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

What should I do if I have this product?

Voluntary: Firm initiated · Letter